XT
LUCD icon

XTX Topco’s Lucid Diagnostics LUCD Stock Holding History

XTX Topco’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-119,529
Closed -$137K – 4478
2026
Q1 		$137K Sell
119,529
-105,931
-47% -$135K ﹤0.01% 2995
2025
Q4 		$246K Buy
+225,460
New +$252K 0.01% 2246
2025
Q1 		– Sell
-25,322
Closed -$20.7K – 2787
2024
Q4 		$20.7K Buy
+25,322
New +$22.3K ﹤0.01% 2032

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

XTX Topco's LUCD Position: Q2 2026 in Review

XTX Topco sold out of Lucid Diagnostics (LUCD) in Q2 2026, closing a stake of 119,529 shares — an estimated $137K sold.

XTX Topco first reported a position in LUCD in Q4 2024 and held it in 3 quarters. The position peaked at $246K in Q4 2025. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • XTX Topco reported no remaining Lucid Diagnostics position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 119,529 Lucid Diagnostics shares in Q2 2026, an estimated $137K.
  • XTX Topco first reported a position in Lucid Diagnostics in Q4 2024 and held it in 3 quarters.
  • XTX Topco's Lucid Diagnostics position peaked at $246K in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.